In-depth reviews of key areas and decisions facing the R&D sector, with recommendations for progress
Rapid analysis of events and data across the sector, offering the perspective of the CaSE team
Political and press letters, as CaSE seeks to push for action on key issues facing the R&D sector

CaSE is celebrating a selection of its achievements from the last decade; here we highlight our attempts to tranform the government’s attitude to investing in science and research from 2010.

Read CaSE’s letter to the House of Lords S&T Committee on Horizon Europe, ODA cuts and medical research charities

Assessing all things Horizon Europe, ODA and more in this comment piece

Policy Officer James Tooze reflects on Dominic Cummings’ appearance before the S&T Committee

An unattributed summary of the roundtable on 21st January 2021, co-hosted by The Physiological Society and CaSE.

Raiding UKRI to fund EU programmes would be a huge step backwards, says Executive Director Prof Sarah Main

The new CaSE Chair Dr Bob Sorrell writes his opening message to CaSE’s members and supporters

Our Assistant Director, Daniel Rathbone, takes a look at what the Brexit Deal means for the research sector

James Tooze looks at the recent release of R&D investment statistics

Executive Director Dr Sarah Main gives her report on CaSE’s activities and successes at the 2020 online AGM on 25th November.

CaSE has written to Greg Clark to ask his Committee to assess the effects of the Covid-19 pandemic on research-intensive businesses in the UK

Read our submission to this inquiry which reviewed the effects of the Covid-19 pandemic on UK research and innovation